Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Jun;31(6):683–687. doi: 10.1111/j.1365-2125.1991.tb05593.x

The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study.

A Kahan 1, S Chaussade 1, M Gaudric 1, B Freitag 1, B Amor 1, C J Menkes 1, G Strauch 1, J Guerre 1, D Couturier 1
PMCID: PMC1368580  PMID: 1867962

Abstract

1. Cisapride is a novel prokinetic drug which facilitates or restores motility throughout the gastrointestinal tract. Its mechanism of action is thought to involve enhancement of acetylcholine release in the myenteric plexus of the gut. 2. The effect of intravenous cisapride 10 mg on gastro-oesophageal dysfunction was investigated in 20 patients with systemic sclerosis, using a double-blind, randomised, cross-over, placebo-controlled manometric study design. 3. The increase in lower oesophageal sphincter pressure was significantly higher after cisapride (mean +/- s.e. mean, 8.3 +/- 2.1 cm H2O) than after placebo (mean +/- s.e. mean. 0.1 +/- 0.3 cm H2O) (P less than 0.001). The increase in the number of fundic gastric contractions during the 30 min study period was significantly higher after cisapride (mean +/- s.e. mean, 7.7 +/- 2.3) than after placebo (mean +/- s.e. mean, 0.9 +/- 0.6) (P less than 0.01). 4. No serious clinical adverse effects were observed. 5. The study demonstrates that intravenous cisapride induces a significant increase in lower oesophageal sphincter pressure and in the number of fundic gastric contractions, which may be beneficial in the treatment of scleroderma gastro-oesophageal dysfunction. Further long-term studies of the effect of oral cisapride in patients with systemic sclerosis are warranted.

Full text

PDF
684

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson M., Summerling M. D. Oesophageal changes in systemic sclerosis. Gut. 1966 Aug;7(4):402–408. doi: 10.1136/gut.7.4.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ceccatelli P., Janssens J., Vantrappen G., Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut. 1988 May;29(5):631–635. doi: 10.1136/gut.29.5.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clements P. J., Kadell B., Ippoliti A., Ross M. Esophageal motility in progressive systemic sclerosis (PSS). Comparison of cine-radiographic and manometric evaluation. Dig Dis Sci. 1979 Aug;24(8):639–644. doi: 10.1007/BF01333709. [DOI] [PubMed] [Google Scholar]
  4. Cohen S., Fisher R., Lipshutz W., Turner R., Myers A., Schumacher R. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest. 1972 Oct;51(10):2663–2668. doi: 10.1172/JCI107084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. D'Angelo W. A., Fries J. F., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969 Mar;46(3):428–440. doi: 10.1016/0002-9343(69)90044-8. [DOI] [PubMed] [Google Scholar]
  6. Feldman M., Smith H. J. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. A comparison with metoclopramide and placebo. Gastroenterology. 1987 Jan;92(1):171–174. doi: 10.1016/0016-5085(87)90854-7. [DOI] [PubMed] [Google Scholar]
  7. Galmiche J. P., Brandstätter G., Evreux M., Hentschel E., Kerstan E., Kratochvil P., Reichel W., Schütze K., Soule J. C., Vitaux J. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Gut. 1988 May;29(5):675–681. doi: 10.1136/gut.29.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilbert R. J., Dodds W. J., Kahrilas P. J., Hogan W. J., Lipman S. Effect of cisapride, a new prokinetic agent, on esophageal motor function. Dig Dis Sci. 1987 Dec;32(12):1331–1336. doi: 10.1007/BF01296657. [DOI] [PubMed] [Google Scholar]
  9. Horowitz M., Maddern G. J., Maddox A., Wishart J., Chatterton B. E., Shearman D. J. Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology. 1987 Aug;93(2):311–315. doi: 10.1016/0016-5085(87)91020-1. [DOI] [PubMed] [Google Scholar]
  10. Jian R., Ducrot F., Piedeloup C., Mary J. Y., Najean Y., Bernier J. J. Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut. 1985 Apr;26(4):352–358. doi: 10.1136/gut.26.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kahan A., Bour B., Couturier D., Amor B., Menkes C. J. Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study. Arthritis Rheum. 1985 May;28(5):490–495. doi: 10.1002/art.1780280504. [DOI] [PubMed] [Google Scholar]
  12. Kahan A., Gerfaux J., Kahan A., Joret A. M., Menkès C. J., Amor B. Increased proto-oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis. Arthritis Rheum. 1989 Apr;32(4):430–436. doi: 10.1002/anr.1780320412. [DOI] [PubMed] [Google Scholar]
  13. Lazzaroni M., Sangaletti O., Bianchi Porro G. Effect of cisapride on gastric emptying and ileal transit time of balanced liquid meal in healthy subjects. Digestion. 1987;37(2):110–113. doi: 10.1159/000199476. [DOI] [PubMed] [Google Scholar]
  14. Maddern G. J., Horowitz M., Jamieson G. G., Chatterton B. E., Collins P. J., Roberts-Thomson P. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology. 1984 Oct;87(4):922–926. [PubMed] [Google Scholar]
  15. McCallum R. W., Prakash C., Campoli-Richards D. M., Goa K. L. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs. 1988 Dec;36(6):652–681. doi: 10.2165/00003495-198836060-00002. [DOI] [PubMed] [Google Scholar]
  16. Müller-Lissner S. A., Fraas C., Härtl A. Cisapride offsets dopamine-induced slowing of fasting gastric emptying. Dig Dis Sci. 1986 Aug;31(8):807–810. doi: 10.1007/BF01296047. [DOI] [PubMed] [Google Scholar]
  17. Petrokubi R. J., Jeffries G. H. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Gastroenterology. 1979 Oct;77(4 Pt 1):691–695. [PubMed] [Google Scholar]
  18. Poirier T. J., Rankin G. B. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol. 1972 Jul;58(1):30–44. [PubMed] [Google Scholar]
  19. Rees W. D., Leigh R. J., Christofides N. D., Bloom S. R., Turnberg L. A. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology. 1982 Sep;83(3):575–580. [PubMed] [Google Scholar]
  20. Russell M. L., Friesen D., Henderson R. D., Hanna W. M. Ultrastructure of the esophagus in scleroderma. Arthritis Rheum. 1982 Sep;25(9):1117–1123. doi: 10.1002/art.1780250913. [DOI] [PubMed] [Google Scholar]
  21. Saladin T. A., French A. B., Zarafonetis C. J., Pollard H. M. Esophageal motor abnormalities in scleroderma and related diseases. Am J Dig Dis. 1966 Jul;11(7):522–535. doi: 10.1007/BF02233564. [DOI] [PubMed] [Google Scholar]
  22. Schuurkes J. A., Van Nueten J. M., Van Daele P. G., Reyntjens A. J., Janssen P. A. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther. 1985 Sep;234(3):775–783. [PubMed] [Google Scholar]
  23. Stacher G., Steinringer H., Schneider C., Winklehner S., Mittelbach G., Gaupmann G. Effects of cisapride on jejunal motor activity in fasting healthy humans. Gastroenterology. 1986 May;90(5 Pt 1):1210–1216. doi: 10.1016/0016-5085(86)90387-2. [DOI] [PubMed] [Google Scholar]
  24. TREACY W. L., BAGGENSTOSS A. H., SLOCUMB C. H., CODE C. F. SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS. Ann Intern Med. 1963 Sep;59:351–356. doi: 10.7326/0003-4819-59-3-351. [DOI] [PubMed] [Google Scholar]
  25. Wallin L., Kruse-Andersen S., Madsen T., Boesby S. Effect of cisapride on the gastro-oesophageal function in normal human subjects. Digestion. 1987;37(3):160–165. doi: 10.1159/000199494. [DOI] [PubMed] [Google Scholar]
  26. Zamost B. J., Hirschberg J., Ippoliti A. F., Furst D. E., Clements P. J., Weinstein W. M. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology. 1987 Feb;92(2):421–428. doi: 10.1016/0016-5085(87)90137-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES